🚀 Free Webinar 🚀 Sign up for our upcoming webinar and learn from aescolab's Co-Founder and Chief Medical Officer Ruth Biallowons about how you can live a more energetic life and how our blood analyses can support you on your journey. You can register for free using the following link: https://lnkd.in/eq2fjPAN (Disclaimer: The webinar will be in German)
aescolab’s Post
More Relevant Posts
-
AVP, Sr. Talent Acquisition Advisor - Belief | Maximizer | Positivity | Developer | Communication
It's inspiring to see our Lockton Chief Medical Officer sharing important perspectives with other leading experts on the evolving GLP-1 weight loss medication landscape. You can check out Lockton's latest article here: http://spr.ly/6042U8oM4
-
Simplify your understanding of Semaglutide adverse reactions with Part 10 of our comprehensive series designed for medical providers. Visit [https://lnkd.in/gsn-ADKe] for additional resources. #SimplifyReactions #ComprehensiveSeries #10
-
Guide to Choosing Clinical Trials Considering participating in a clinical trial? Educate yourself with our comprehensive guide at clincalstage.net. Learn about phases, benefits, and what to consider before making an informed decision. Empower yourself with knowledge and explore how you can contribute to medical breakthroughs. #ClinicalTrialGuide #InformedDecisions #HealthcareChoices
-
-
👇Meet the expert speakers of our our upcoming webinar! 💡Prof Henning Bliddal will provide an insightful presentation on "#Weightloss and medical management of #osteoarthritis" which will be followed by Q&A. 🔗Click on the link in the comment to see the full agenda and register for free.
-
-
Simplify your understanding of Semaglutide adverse reactions with Part 11 of our comprehensive series designed for medical providers. Visit [https://lnkd.in/gsn-ADKe] for additional resources. #SimplifyReactions #ComprehensiveSeries #11
-
WE PROVIDE PEOPLE SOLUTIONS. CFO. CHRO, HR Director, Owners and Risk Managers come to us to solve their problems.,
GLP 1's and the impact to employers and employees...follow the data....
Vice President, Executive Medical Director for Lockton | Internal Medicine Physician | Physician Executive | Clinical Strategist
It's inspiring to see our Lockton Chief Medical Officer, Dr. Shealynn Buck, sharing important perspectives with other leading experts on the evolving hot topic of the GLP-1 weight loss medication landscape. You can check out Lockton's latest article here: http://spr.ly/6042UYNQu
-
Curious about the common pitfalls in the clinical trial site selection process? Spend a few minutes watching the below video as NAMSA's Chief Medical Officer Dr. Ken Ouriel shares helpful insights to overcome these challenges as well considerations for partnering with MedTech focused CRO’s to help navigate this potentially time consuming aspect to bringing lifesaving technologies to market. Please reach out if you're looking for a MedTech focused CRO for your next clinical trial.
🚀 Episode 10 of the MedTech Matters Video series is now live! Join us as Dr. Kenneth Ouriel, Chief Medical Officer at NAMSA, delves into the crucial Strategies for Selecting the Proper Investigational Sites for Pivotal Studies. 🏥 Discover expert insights on optimizing your clinical trials for success. Don't miss out on this invaluable resource for medical device professionals! 🎥 Watch now and elevate your study strategy: https://lnkd.in/gj7-au2q #MedTechMatters #ClinicalTrials #MedicalDevices #NAMSAKnows #PivotalStudies
-
IN 10 MINS Join TEN Capital Network and Entac Medical for an investor update and to hear about the latest updates on Entac Medical. Register now: https://bit.ly/4bCJLlk #tencapitalevents #investorupdate #entacmedical
-
-
IN 10 MINS Join TEN Capital Network and Entac Medical for an investor update and to hear about the latest updates on Entac Medical. Register now: https://bit.ly/4bCJLlk #tencapitalevents #investorupdate #entacmedical
-
